Secondary Logo

Journal Logo

Advanced Search

Video Gallery

Uterine Fibroids in Menopause and Perimenopause

Video Author: Paige Wynne
Video Production Specialist
Creative and Digital Services
University of Illinois at Chicago
Published on: 01.22.2020
Associated with: February 2020, Volume 27, Issue 2; Menopause. 27(2):238-242, February 2020

In this video, we glimpse the significance of Uterine fibroid disease and highlights their unusual persistence in menopause women. Moreover, we discuss the possible available treatment options as well as the advantages and disadvantages of using hormonal therapy in this specific population.

Related Videos

All Videos
Most Viewed
Most Emailed



Managing Sexual Dysfunction in Women with Cancer: A Systematic Review of the Evidence
Creator: Dr. Jennifer Marino
Duration: 2:51
This video describes a systematic review of the efficacy of available interventions for sexual dysfunction in women after cancer.
Play Video |
Toward a better measure of midlife sexual function: pooled analysis in nearly 1000 women participating in MsFLASH randomized trials
Creator: Caroline Mitchell
Duration: 5:36
In this video we discuss analysis of Female Sexual Function Index (FSFI) responses in close to 1000 women, and identify a score cutoff that more closely correlates with sexually-related personal distress (as measured by the FSDS-R) in postmenopausal and perimenopausal women.
Play Video |
Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism
Creator:
Duration: 5:16
This video is a summary of the manuscript titled ‘Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism.’ The video discusses briefly the background, purpose, results, and conclusions of this study. Peri-menopause may be the optimal window for intervention, and these women should aim to prevent losses of fat-free mass and decrements in metabolism by participating in resistance and high-intensity exercise.
Play Video |
Psychological Well-Being of Midlife Women
Creator: Jiwon Lee, PhD
Duration: 4:01
This study used a structural equation model to test the significance of factors associated with the psychological well-being of midlife women in South Korea based on the transactional model of stress and coping. Self-efficacy (exogenous variable) was positively associated with the psychological well-being (endogenous variable) of middle-aged women and appeared to be mediated by perceived stress, menopausal management, menopausal symptoms, and self-compassion. The predictor variables had an explanatory power of 79.5% for psychological well-being. These results can be helpful in the future development of interventions to improve psychological well-being by improving self-efficacy and coping with stress in middle-aged women.
Play Video |
Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms
Creator: Michael McClung, MD; Sponsored by TherapeuticsMD
Duration: 4:41
In this video, Dr. Michael McClung describes the effects of preparations combining 0.5 mg and 1.0 mg 17β-estradiol with 100 mg of progesterone on biochemical markers of bone metabolism in postmenopausal women with a uterus who were having moderate to severe vasomotor symptoms. This was a post hoc analysis in a subset of women in the REPLENISH study that evaluated the effects of these preparations on vasomotor symptoms. Both of the combined hormone preparations significantly reduced markers of bone resorption and formation at 6 and 12 months of therapy. The research described by Dr McClung suggests that these combinations of estradiol and progesterone may have skeletal benefit in addition to improving vasomotor symptoms in postmenopausal women.
Play Video |
NT-proBNP, Menopause and Heart Failure
Creator: Aniekan Akpaffiong
Duration: 4:01
The influence of early menopause on the relationship between NT-proBNP and heart failure in postmenopausal women.
Play Video |
Oral Contraceptives Tubal Ligation and AMH - Langton
Creator: Christine R. Langton
Duration: 3:28
This video provides a brief overview of research examining the association of oral contraceptives, tubal ligation, and anti-Müllerian hormone in the Nurses’ Health Study II cohort.
Play Video |
Is the cognitive performance of women sensitive to the severity of menopausal symptoms?
Creator: Mankamal Kaur
Duration: 4:54
The video summarizes the statistical methods used and the major findings of the research article entitled ‘Is the cognitive performance of women sensitive to the severity of menopausal symptoms?’. The clinical implications of the current research has also been discussed in the video.
Play Video |
Decision aids and shared decision making in urogynecology
Creator: May Wakamatsu, MD
Duration: 4:15
The video describes the importance of shared decision making and the use of decision aids with patients who are considering treatment for pelvic organ prolapse and urinary incontinence.
Play Video |
Factors affecting surgical decision making in carriers of BRCA1/2 pathogenic variants undergoing risk reducing surgery at a dedicated hereditary ovarian cancer clinic
Creator: Michelle Jacobson MD FRCSC NCM
Duration: 3:54
This video summarizes the paper entitled “Factors Affecting Surgical Decision Making in Carriers of Pathogenic BRCA1/2 Variants at a Hereditary Ovarian Cancer Clinic” and describes the role of the dedicated hereditary ovarian cancer clinic at a tertiary care centre.
Play Video |
Gastrointestinal symptoms in four major racial/ethnic groups of midlife women: race/ethnicity and menopausal status
Creator: Gayeong Kim
Duration: 6:07
The purpose of this study was to explore the associations of race/ethnicity and menopausal status to gastrointestinal (GI) symptoms experienced during the menopausal transition while considering multiple factors that could influence the symptoms.
Play Video |
Prevalence and factors associated with overactive bladder and stress urinary incontinence in the Japan Nurses' Health Study
Creator: Kazue Nagai
Duration: 5:21
Symptoms of urinary incontinence (e.g., stress urinary incontinence [SUI]) are relatively common in women. Furthermore, overactive bladder (OAB) syndrome occurs in approximately 10% of women. Symptoms of these conditions affect health-related quality of life. Therefore, a better understanding of the prevalence and associated factors of these urinary symptoms is required for improving and preventing these symptoms. This study investigated the prevalence and factors associated with urinary symptoms using cross-sectional data from the Japan Nurses’ Health Study in 12,198 women. The prevalence of OAB was 9.5%, that of SUI was 13.9%, and that of mixed urinary incontinence was 2.1%. Age 45-54 years and postmenopausal status was significantly associated with OAB, and age group (45–49 and 50–54 years), body mass index, and parous status were significantly associated with the risk of SUI.
Play Video |
Inner metacarpal bone diameter in adult women increases while bone mineral density decreases during and after menopause, assessed by Digital X Ray Radiogrammetry
Creator: Dr. Carl Samuelsson
Duration: 3:50
Overview and summary of paper regarding bone morphology parameters measured by DXR. Powerpoint video with author going through the paper. Inner diameter of metacarpals increases in a similar fashion that bone mineral density decreases. Avenue for a screening tool?
Play Video |
Subtypes in menopausal symptoms
Creator: PING LI
Duration: 04:26
This video describes research investigating the existence of significant subgroups of women with similar menopausal symptoms. There are four subtypes of menopause symptoms in middle-aged women, namely, ‘severe symptoms’, ‘dominant sleep-emotion symptoms’, ‘physical/mental exhaustion symptoms’, and ‘no symptoms’ classes.
Play Video |
Natural menopausal age and cardiovascular disease risk factors in older Chinese women: Guangzhou Biobank Cohort Study
Creator: Huimin Su
Duration: 04:45
Video summary of the associations of natural menopausal age with cardiovascular disease risk factors, and the modification effect of parity.
Play Video |
Highlights of the research paper on primary care physicians and gynecologists' knowledge about menopause and their attitudes to hormone therapy use in Jamaica
Creator: Dr. Carole Rattray
Duration: 03:39
A conversational introduction to the research study entitled: “Mind the gap: primary care physicians and gynecologists' knowledge about menopause and their attitudes to hormone therapy use in Jamaica”.
Play Video |
Quality of life during menopause transition
Creator:
Duration: 03:02
Video summary of the randomized clinical trial study that focused determining the effect of midwifery-oriented group counseling based on the GATHER model on the quality of life of women during the transition to menopause.
Play Video |
Effects of menopausal hormone therapy on cardiovascular diseases and type 2 diabetes in middle-aged postmenopausal women: Analysis of the Korea National Health Insurance Service database
Creator: Ji-Eun Kim
Duration: 03:13
Using the National Health Insurance Service database of Korea, this study examined the associations of MHT with cardiovascular diseases (CVDs) and type 2 diabetes among middle-aged postmenopausal women. This study is meaningful in evaluating these associations in Asian postmenopausal women, who were rarely included in large-scale randomized controlled trials. In addition, the time-related issues such as the immortal-time bias and the latency time bias raised from healthcare databases were corrected in the analyses.
Play Video |
Menopausal hormone therapy and risk of incident hypertension
Creator: Conor James MacDonald
Duration: 03:05
Summary of article exploring associations between menopausal hormone therapy and risk of incident hypertension, published in Menopause
Play Video |
Obesity and metabolic syndrome induce hyperfiltration, glomerulomegaly and albuminuria in obese castrated female mice and obese male mice
Creator: The video was created by the authors of the article: Dr. Esteban Porrini (Voice) and Dr. Ana E. Rodríguez (design)
Duration: 07:55
In this video Dr. Esteban Porrini explains, in a presentation PowerPoint, all details of our article.
Play Video |



Managing Sexual Dysfunction in Women with Cancer: A Systematic Review of the Evidence
Creator: Dr. Jennifer Marino
Duration: 2:51
Show More 
Show Less 
This video describes a systematic review of the efficacy of available interventions for sexual dysfunction in women after cancer.
Play Video |
Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism
Creator:
Duration: 5:16
Show More 
Show Less 
This video is a summary of the manuscript titled ‘Metabolic effects of menopause: a cross-sectional characterization of body composition and exercise metabolism.’ The video discusses briefly the background, purpose, results, and conclusions of this study. Peri-menopause may be the optimal window for intervention, and these women should aim to prevent losses of fat-free mass and decrements in metabolism by participating in resistance and high-intensity exercise.
Play Video |
NT-proBNP, Menopause and Heart Failure
Creator: Aniekan Akpaffiong
Duration: 4:01
Show More 
Show Less 
The influence of early menopause on the relationship between NT-proBNP and heart failure in postmenopausal women.
Play Video |
Oral Contraceptives Tubal Ligation and AMH - Langton
Creator: Christine R. Langton
Duration: 3:28
Show More 
Show Less 
This video provides a brief overview of research examining the association of oral contraceptives, tubal ligation, and anti-Müllerian hormone in the Nurses’ Health Study II cohort.
Play Video |
Is the cognitive performance of women sensitive to the severity of menopausal symptoms?
Creator: Mankamal Kaur
Duration: 4:54
Show More 
Show Less 
The video summarizes the statistical methods used and the major findings of the research article entitled ‘Is the cognitive performance of women sensitive to the severity of menopausal symptoms?’. The clinical implications of the current research has also been discussed in the video.
Play Video |
Prevalence and factors associated with overactive bladder and stress urinary incontinence in the Japan Nurses' Health Study
Creator: Kazue Nagai
Duration: 5:21
Show More 
Show Less 
Symptoms of urinary incontinence (e.g., stress urinary incontinence [SUI]) are relatively common in women. Furthermore, overactive bladder (OAB) syndrome occurs in approximately 10% of women. Symptoms of these conditions affect health-related quality of life. Therefore, a better understanding of the prevalence and associated factors of these urinary symptoms is required for improving and preventing these symptoms. This study investigated the prevalence and factors associated with urinary symptoms using cross-sectional data from the Japan Nurses’ Health Study in 12,198 women. The prevalence of OAB was 9.5%, that of SUI was 13.9%, and that of mixed urinary incontinence was 2.1%. Age 45-54 years and postmenopausal status was significantly associated with OAB, and age group (45–49 and 50–54 years), body mass index, and parous status were significantly associated with the risk of SUI.
Play Video |
Impact of Sleep Disturbances on Employment and Work Productivity Among Midlife Women in the US SWAN Database: A Brief Report
Creator: Risa Kagan, MD
Sponsored by Astellas Pharma Inc
Duration: 04:23
Show More 
Show Less 
In this video, Dr. Risa Kagan describes findings from a recent study of the impact of new-onset sleep disturbances on employment and work productivity in midlife women. This retrospective, longitudinal cohort analysis used data from the Study of Women’s Health Across the Nation (SWAN), encompassing a multiracial group of women across the United States. Results showed that the risk of unemployment was higher following new-onset sleep disturbances than it is in women without sleep disturbances. The research described by Dr. Kagan also quantified the individual costs and societal economic burden associated with work productivity loss associated with new-onset sleep disturbance in midlife women.
Play Video |
Weight regulation in menopause
Creator: Dr. Michael G. Knight
Duration: 2:38
Show More 
Show Less 
Obesity is an epidemic that affects post-menopausal women at increased rates. This review discusses the physiology, assessment, and effective treatment strategies for the treatment of obesity in this population.
Play Video |
Zhao Menopause 2021
Creator: Dr. Jennifer Smith
Duration: 2:32
Show More 
Show Less 
This video describes research investigating the genetic factors associated with vasomotor symptoms in a multi-racial/multi-ethnic cohort, as presented in Zhao, et al., Menopause, 2021.
Play Video |
Effect of an educational intervention on women's healthcare provider knowledge gaps about breast density, breast cancer risk, and screening
Creator: Robin Seitzman, PhD, MPH
Duration:
Show More 
Show Less 
Overview of a study to assess the effect of a web-based educational intervention on women’s healthcare provider knowledge of breast density, its risk and screening implications, and comfort level in discussing these topics with patients.
Play Video |
Equol and Obesity
Creator: Atsushi Takahashi
Duration: 3:28
Show More 
Show Less 
In this video, Dr. Takahashi provides a summary of article　“Association of equol with obesity in postmenopausal women.”
Play Video |
Depressive Symptoms and Type II Diabetes Mellitus Among Midlife Women
Creator: Jee-Seon Yi
Duration: 4:38
Show More 
Show Less 
A decision tree analysis on the associations of type II diabetes mellitus (DM) to depressive symptoms among midlife women from four major racial/ethnic groups in the U.S.
Play Video |
Genitourinary syndrome of menopause: A systematic review on prevalence and treatment
Creator: Nikoletta Mili
Duration: 6:03
Show More 
Show Less 
Video summary of the article entitled “Genitourinary syndrome of menopause: A systematic review on prevalence and treatment”. This article aimed to systematically review the literature to investigate the prevalence of GSM and its treatment. GSM is a highly prevalent condition among women. Nevertheless, women are frequently not aware of its cause and its treatment options. The findings of this review underline the need for education of patients and health care professionals regarding GSM diagnosis and treatment options.
Play Video |
Efficacy of progesterone-only treatment for the management of menopausal symptoms: A systematic review
Creator: Sarah Sheehan Stadler, MD
Duration: 3:51
Show More 
Show Less 
Review of literature regarding progesterone only for the management of menopausal symptoms
Play Video |
Perimenopausal vasomotor symptoms and the cortisol awakening response
Creator: Jennifer Gordon
Duration: 3:45
Show More 
Show Less 
Summary of “Perimenopausal vasomotor symptoms and the cortisol awakening response”
Play Video |
The role of commonly prescribed medications and weight gain in menopause- A Women’s Health Initiative study
Creator: Fatima Cody Stanford, MD, MPH, MPA
Duration: 5:25
Show More 
Show Less 
This video explains how weight promoting medications may lead to weight gain in women during menopause. It should be noted that hormonal changes associated with menopause already lead to weight gain. However, weight gain may be exacerbated with the use of several commonly prescribed medications.
Play Video |
Unique and Enduring Impact of Adverse Childhood Adversity on Executive Function After RRSO
Creator: CU-Anschutz Medical Campus, Office of Communications (contact Kristen O’Neill)
Duration: 1:51
Show More 
Show Less 
C. Neill Epperson, MD, Chair and Robert Freedman Endowed Professor of Psychiatry at the University of Colorado-Anschutz Medical Campus highlights the significance of their study focusing on subjective and objective executive function difficulties after surgical menopause. While negative mood states (anxiety/depression) are common among individuals who endorse adverse childhood experiences (ACEs), these symptoms did not fully explain the relationship between ACEs and subjective executive function complaints or performance on working memory and sustained attention tasks. These data suggest that ACEs exert an enduring negative impact on cognition among women who experience new-onset executive function complaints after RRSO.
Play Video |
Depression, hormone therapy and the menopausal transition among women aged 45-64 years using Canadian Longitudinal Study on Aging baseline data
Creator: Alison Shea
Duration: 5:07
Show More 
Show Less 
The menopause transition is a vulnerable time for mental health and it is important to better understand the risk factors for depression during this time. This study using baseline data from the Canadian Longitudinal Study on Aging shows that premature menopause and the use of hormone therapy, as well as low education, low household income, living alone, being nulliparous, and having low social support are associated with current depression measured using the Center for Epidemiologic studies Short Depression Scale.
Play Video |
Cervicovaginal lavage fluid zinc level as a marker of vaginal atrophy
Creator: Bence Kozma MD PhD / No Sponsor
Duration: 3:15
Show More 
Show Less 
Many studies suggest that zinc levels may correlate with some vaginal conditions, but the role in the diagnosis of Genitourinary syndrome of Menopause or Vulvovaginal Atrophy is not known. Cervicovaginal lavage has been widely used to investigate changes in the vagina. In our prospective cohort study the multivariate regression model revealed a significant association between vaginal atrophy and cervicovaginal lavage zinc levels. Measuring the amount of zinc in cervicovaginal lavage could aid in the diagnosis of Genitourinary syndrome of Menopause. Zinc levels of cervicovaginal lavage could be used as a new marker of vaginal atrophy.
Play Video |
Mental well-being and menopause
Creator: Dmitriy Bondarev
Duration: 4:32
Show More 
Show Less 
Mental well-being and menopause
Play Video |
Safety of Vaginal Estrogens: A Recap of a Systematic Review
Creator: Carolyn J. Crandall, MD, MS
Duration: 4:34
Show More 
Show Less 
In this video, Dr. Carolyn J. Crandall describes the key findings and clinical “take-home messages” of the systematic review regarding safety of vaginal estrogens that her team recently performed.
Play Video |
Hot Flashes, Memory and Brain Function
Creator: Pauline Maki
Duration: 3:31
Show More 
Show Less 
This video describes results from a recent study examining the association between physiologic hot flashes and brain function as women learn and remember words.
Play Video |
“Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy”
Creator: Benjamin S. Harris, MD, MPH
Duration: 2:49
Show More 
Show Less 
The risks and benefits of hormone therapy in perimenopausal women have been extensively studied. Less is known about hormone therapy in breast or gynecologic cancer survivors and risk of cancer recurrence. We reviewed the available data to determine whether hormone therapy is safe for breast, ovarian, endometrial, and cervical cancer survivors. We also present a mechanism of reducing breast cancer incidence through estrogen-driven apoptosis pathways, and discuss the role of progestins in the growth of breast cancer stem cells. These concepts are a foundation for future research into the role of hormone replacement in treatment and prevention of breast cancer.
Play Video |
Uterine Fibroids in Menopause and Perimenopause
Creator: Paige Wynne
Video Production Specialist
Creative and Digital Services
University of Illinois at Chicago
Duration: 3:34
Show More 
Show Less 
In this video, we glimpse the significance of Uterine fibroid disease and highlights their unusual persistence in menopause women. Moreover, we discuss the possible available treatment options as well as the advantages and disadvantages of using hormonal therapy in this specific population.
Play Video |
The Vaginal Laser Therapy versus Vaginal Estrogen Therapy: The VeLVET Trial
Creator: David Rogant, Cleveland Clinic
Duration: 2:49
Show More 
Show Less 
This video presents our impetus to embark on this randomized trial and the significance of our manuscript. We discuss the innovative use of CO2 fractional laser therapy for the treatment of genitourinary syndrome of menopause (GSM) and compare it to gold standard therapy. We summarize our thoughts regarding clinical applicability of the CO2 fractional laser for GSM and make our recommendations for future work in studying its long-term efficacy and safety.
Play Video |
Hysterectomy and its association with Mental Health
Creator: Shannon Laughlin-Tommaso
Duration:
Show More 
Show Less 
In this video, we discuss how hysterectomy, even with ovarian conservation, increased the long-term risks of depression and anxiety by over 20% compared with referent women. In this population-based cohort with 20 years of follow-up, hysterectomy with ovarian conservation was associated an absolute risk increase of 7% for depression and 5% for anxiety. Women who had a hysterectomy before age 36 had even higher absolute risk increases: 12% for depression and 10% for anxiety.
Play Video |
Exercise and physical function in postmenopausal women
Creator: Paulo Ricardo Prado Nunes
Duration: 03:26
Show More 
Show Less 
- The exercise guidelines recommend 150 minutes/week of combined training (CT), aerobic and resistance exercises, for improvements in body composition (BC), muscle strength (MS) and physical function (PF). However, the lack of time and access to physical training facilities are commons barriers for people not to comply with the exercise guidelines.

- The high-intensity interval training (60 minutes/week - HIIT) is an exercise strategy to overcome the time commitment problem. However, there is no evidence regarding the HIIT effects on MS and PF.

- This study compared the effects of HIIT with CT on PF, BC and MS in obese postmenopausal women.
Play Video |
Evidence Map of Ductal Carcinoma In Situ (DCIS) Management Options
Creator: Kathryn Bouskill et al., RAND Corporation
Duration: 4:26
Show More 
Show Less 
This video presents an evidence map and online, interactive decision tool depicting the robustness and topical span of research on DCIS management choice on patient-centered and clinical outcomes. These tools are useful for highlighting priority areas for clinicians seeking to counsel patients regarding patient-centered outcomes for various management options for DCIS.
Play Video |
Are women still sexually active after menopause?
Creator: Sussex Health Outcomes Research & Education in Cancer; filmed and edited by Matt Bemment, Communication Assistant, Brighton and Sussex Medical School
Duration: 4:35
Show More 
Show Less 
What do we really know about sex after menopause? This video summary reports on the results of a free-text analysis on sexual activity in over 4,400 postmenopausal women who took part in UKCTOCS, a large UK ovarian cancer screening trial. It shows that sexuality can change when we get older and that relationship status and health have a direct effect on sexuality and satisfaction. We believe it is important to raise awareness among women and healthcare professionals to increase the understanding of sexual issues women may face in later life.
Play Video |
Visual Assessment of Genital Health in Menopausal Women
Creator: Irwin Goldstein, MD
Duration: 3:48
Show More 
Show Less 
This is a phase 3 pivotal trial of ospemifene versus placebo in women in menopause with moderate to severe vaginal dryness, a symptom of GSM. On physical examination, such women commonly have vulvar, vestibular and vaginal atrophy. This study, for the first time, utilized vulvar vestibular photography to objectively document changes in genital health. There were no changes noted in photography on placebo, however active therapy with a SERM resulted in regrowth of labia minora, normalization of the urethral gland prominence, resolution of the pallor and erythema of the vestibule and visualization of vestibular moisture. Visual assessment of genital health in such patients should be utilized in future trials.
Play Video |